Taysha Gene Therapies, Inc. (TSHA) Earnings
NASDAQ·Healthcare·Biotechnology
$4.91
-5.04%
Mkt Cap $1.65B
EPS — Estimate vs Actual
Mkt Cap
$1.65B
P/E
—
Fwd P/E
—
P/S
220.92
Rev TTM
—
EPS TTM
-$0.38
NASDAQ·Healthcare·Biotechnology
$4.91
-5.04%
Mkt Cap $1.65B
Mkt Cap
$1.65B
P/E
—
Fwd P/E
—
P/S
220.92
Rev TTM
—
EPS TTM
-$0.38